19 October 2018 - - US-based biotechnology company Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) has appointed Francois Lebel, M.D., F.R.C.P.C. as chief medical officer, the company said.
Lebel will be responsible for leading the Spectru...
You are required to be logged in to access the full website
Click here if you have forgotten your username or password
19 October 2018 - - A pivotal Phase 3 KEYNOTE-426 trial investigating US-based biopharmaceutical company Merck's (NYSE: MRK) Keytruda (pembrolizumab), Merck's anti-PD-1 therapy, in combination with Inlyta (axitinib), Pfizer's (NYS...
19 October 2018 - - US-based molecular diagnostics company Co-Diagnostics, Inc.'s (NASDAQ: CODX) Logix Smart Zika Test technical file has obtained CE mark approval, the principle regulatory clearance allowing the test to be sold as an in vi...
19 October 2018 - Chinese biopharmaceutical company Innovent Biologics Inc revealed on Thursday that it has dosed the first patient with advanced solid tumors under a phase I clinical trial of anti-CTLA-4 (Cytotoxic T Lymphocyte-associated Antigen-4)...
19 October 2018 - Biotechnology company Morphic Therapeutic said on Thursday that it plans to advance a number of its oral integrin therapeutics for fibrosis-related indications under a research and development collaboration with AbbVie (NYSE:ABBV) s...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe